Get started
Author

Davide Manissero

Observed names: D Manissero, D. Manissero, Davide Manisero, MANISSERO D, MANISSERO D., Manissero, D, Manissero, Davide
Observed institutions: Otsuka (Japan), University of Insubria, Health Protection Agency, CHU Dijon Bourgogne, Research Center Borstel - Leibniz Lung Center, Qiagen (United Kingdom), Health Protection Agency, University College London, European Centre for Disease Prevention and Control
ORCID: 0000-0002-8887-8795
Observed ORCID: 0000-0002-8887-8795
OpenAlex ID: A5050707844
Interferon-γ release assays for the diagnosis of latentMycobacterium tuberculosisinfection: a systematic review and meta-analysis
2010 · R. Diel, D. Goletti, et al. · European Respiratory Journal · 552
PDF
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis
2010 · M. Sester, G. Sotgiu, et al. · European Respiratory Journal · 545
PDF
A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19
2020 · Sonia N. Rao, Davide Manissero, et al. · Infectious Diseases and Therapy · 414
PDF
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
2012 · Vija Skripconoka, Manfred Danilovits, et al. · European Respiratory Journal · 341
PDF
European Union Standards for Tuberculosis Care
2012 · G.B. Migliori, J.P. Zellweger, et al. · European Respiratory Journal · 207
PDF
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review
2020 · Zaira R. Palacios-Baena, Maddalena Giannella, et al. · Clinical Microbiology and Infection · 172
Measuring tuberculosis burden, trends, and the impact of control programmes
2008 · C Dye, A Bassili, et al. · The Lancet Infectious Diseases · 171
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins
2021 · Florian Wagenlehner, Ersilia Lucenteforte, et al. · Clinical Microbiology and Infection · 163
PDF
Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak
2020 · Luis Peñarrubia, Maria Ruiz, et al. · International Journal of Infectious Diseases · 157
Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations
2009 · E. Klinkenberg, D. Manissero, et al. · European Respiratory Journal · 133
PDF
Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis
2011 · Marieke J. van der Werf, Miranda W. Langendam, et al. · European Respiratory Journal · 128
PDF
A Systematic Review of the Effect of Delayed Appropriate Antibiotic Treatment on the Outcomes of Patients With Severe Bacterial Infections
2020 · Evan J. Zasowski, Matteo Bassetti, et al. · CHEST Journal · 126
PDF
Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections
2020 · Matteo Bassetti, Jordi Rello, et al. · International Journal of Antimicrobial Agents · 122
Social determinants of tuberculosis in Europe: a prospective ecological study
2012 · George B. Ploubidis, Melissa J. Palmer, et al. · European Respiratory Journal · 93
PDF
In vitroactivity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe
2020 · Christopher Longshaw, Davide Manissero, et al. · JAC-Antimicrobial Resistance · 81
PDF
Managing latent tuberculosis infection and tuberculosis in children
2018 · I. Carvalho, D. Goletti, et al. · Pulmonology · 79
PDF
Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review
2013 · Andreas Sandgren, Monica Sañé Schepisi, et al. · European Respiratory Journal · 79
PDF
Childhood tuberculosis: progress requires an advocacy strategy now
2012 · Andreas Sandgren, Luis E. Cuevas, et al. · European Respiratory Journal · 76
PDF
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
2012 · G.B. Migliori, G. Sotgiu, et al. · European Respiratory Journal · 75
PDF
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
2021 · Soumya Jaganathan, Francis Stieber, et al. · Infectious Diseases and Therapy · 74
PDF
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
2021 · Delia Goletti, Linda Petrone, et al. · Clinical Microbiology and Infection · 68
PDF
Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009
2011 · A Sandgren, V Hollo, et al. · Eurosurveillance · 68
PDF
Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones
2012 · Giovanni Battista Migliori, Miranda W. Langendam, et al. · European Respiratory Journal · 67
PDF
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting
2021 · Zahra Sadouki, Timothy D. McHugh, et al. · Journal of Antimicrobial Chemotherapy · 57
PDF
Tuberculosis and HIV co-infection in European Union and European Economic Area countries
2011 · L. Pimpin, L.N. Drumright, et al. · European Respiratory Journal · 56
PDF
Works count: 104
Citation count: 5,289
H-index: 36
I10-index: 67
Year
Topic
Type